{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:08:01Z","timestamp":1791518881395,"version":"4.3.4"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI117287"],"award-info":[{"award-number":["R01 AI117287"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI128821"],"award-info":[{"award-number":["R01 AI128821"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI109946"],"award-info":[{"award-number":["U19 AI109946"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Due to limitations of current influenza virus vaccines, new vaccines that mediate broad protection and show high efficacy against seasonal and pandemic viruses are urgently needed. The conserved stalk of the viral hemagglutinin has been identified as potential target antigen for this new generation of vaccines. A vaccination strategy based on chimeric hemagglutinin (cHA), which refocuses the immune response toward the stalk domain and the conserved neuraminidase, is currently being tested in clinical trials. Here we discuss how to improve the cHA antigens to generate vaccine candidates that both induce a broad antistalk response and target conserved immunosubdominant epitopes in the head domain of the hemagglutinin. These novel constructs, termed mosaic hemagglutinins, should provide enhanced protection and should be tested in clinical trials to assess their improved potential as universal influenza virus vaccine candidates.<\/jats:p>","DOI":"10.1093\/infdis\/jiy711","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T04:20:19Z","timestamp":1545538819000},"page":"S62-S67","source":"Crossref","is-referenced-by-count":99,"title":["Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"first","affiliation":[{"name":"Department of, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"first","affiliation":[{"name":"Department ofMicrobiology, Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2020040720052323200_CIT0001","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The pathway to a universal influenza vaccine","volume":"47","author":"Paules","year":"2017","journal-title":"Immunity"},{"key":"2020040720052323200_CIT0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1714916","article-title":"Chasing seasonal influenza\u2014the need for a universal influenza vaccine","volume":"378","author":"Paules","year":"2018","journal-title":"N Engl J Med"},{"key":"2020040720052323200_CIT0003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2020040720052323200_CIT0004","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","article-title":"Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly","volume":"61","author":"de Jong","year":"2000","journal-title":"J Med Virol"},{"key":"2020040720052323200_CIT0005","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0006","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J Infect Dis"},{"key":"2020040720052323200_CIT0007","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"key":"2020040720052323200_CIT0008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41594-018-0025-9","article-title":"Structural insights into the design of novel anti-influenza therapies","volume":"25","author":"Wu","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"2020040720052323200_CIT0009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2018.03.025","article-title":"Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness","volume":"53","author":"Eichelberger","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"2020040720052323200_CIT0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2018.03.024","article-title":"Vaccine options for influenza: thinking small","volume":"53","author":"Schepens","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"2020040720052323200_CIT0011","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6020018","article-title":"Harnessing the power of T cells: the promising hope for a universal influenza vaccine","volume":"6","author":"Clemens","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"2020040720052323200_CIT0012","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030036","article-title":"The role of Fc gamma receptors in broad protection against influenza viruses","volume":"6","author":"Thulin","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"2020040720052323200_CIT0013","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coi.2018.04.001","article-title":"Development of next generation hemagglutinin-based broadly protective influenza virus vaccines","volume":"53","author":"Nachbagauer","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"2020040720052323200_CIT0014","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0042-6822(83)90465-8","article-title":"Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants","volume":"126","author":"Graves","year":"1983","journal-title":"Virology"},{"key":"2020040720052323200_CIT0015","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0016","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JVI.68.1.517-520.1994","article-title":"Protection against the mouse-adapted A\/FM\/1\/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains","volume":"68","author":"Okuno","year":"1994","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0017","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","article-title":"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies","volume":"105","author":"Kashyap","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0018","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"2020040720052323200_CIT0019","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"2020040720052323200_CIT0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"2020040720052323200_CIT0021","doi-asserted-by":"crossref","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci Transl Med"},{"key":"2020040720052323200_CIT0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"2020040720052323200_CIT0023","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"2020040720052323200_CIT0024","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"2020040720052323200_CIT0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-018-0063-7","article-title":"Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge","volume":"3","author":"van der Lubbe","year":"2018","journal-title":"NPJ Vaccines"},{"key":"2020040720052323200_CIT0026","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0027","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/JVI.03060-15","article-title":"Influenza A viruses expressing intra- or intergroup chimeric hemagglutinins","volume":"90","author":"Chen","year":"2016","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0028","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model","volume":"91","author":"Ermler","year":"2017","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0029","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1073\/pnas.1200039109","article-title":"Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses","volume":"109","author":"Pica","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0030","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0031","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"2020040720052323200_CIT0032","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0033","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/JVI.03004-13","article-title":"Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0034","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0035","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"2020040720052323200_CIT0036","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0037","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0038","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","author":"Nachbagauer","year":"2016"},{"key":"2020040720052323200_CIT0039","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JVI.02598-15","article-title":"Vaccination with vesicular stomatitis virus-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains","volume":"90","author":"Ryder","year":"2015","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2018.03.013","article-title":"Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin","volume":"518","author":"Isakova-Sivak","year":"2018","journal-title":"Virology"},{"key":"2020040720052323200_CIT0041","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0042","doi-asserted-by":"crossref","first-page":"e1003067","DOI":"10.1371\/journal.ppat.1003067","article-title":"Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses","volume":"8","author":"Tsibane","year":"2012","journal-title":"PLoS Pathog"},{"key":"2020040720052323200_CIT0043","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1128\/JVI.00700-11","article-title":"A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin","volume":"85","author":"Krause","year":"2011","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0044","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/JVI.00420-14","article-title":"Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses","volume":"88","author":"Iba","year":"2014","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0045","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1128\/JVI.03562-13","article-title":"A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head","volume":"88","author":"Benjamin","year":"2014","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0046","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1073\/pnas.1715471115","article-title":"Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody","volume":"115","author":"Raymond","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0047","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbrc.2014.09.008","article-title":"A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses","volume":"452","author":"Boonsathorn","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"2020040720052323200_CIT0048","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"2020040720052323200_CIT0049","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/JVI.07158-11","article-title":"Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses","volume":"86","author":"Krause","year":"2012","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0050","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/ncomms4614","article-title":"Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus","volume":"5","author":"Lee","year":"2014","journal-title":"Nat Commun"},{"key":"2020040720052323200_CIT0051","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.1212371109","article-title":"Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0052","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","article-title":"Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med"},{"key":"2020040720052323200_CIT0053","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coi.2018.04.002","article-title":"Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus","volume":"53","author":"Tan","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"2020040720052323200_CIT0054","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam5752","article-title":"A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses","volume":"9","author":"Shen","year":"2017","journal-title":"Sci Transl Med"},{"key":"2020040720052323200_CIT0055","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci Rep"},{"key":"2020040720052323200_CIT0056","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J Clin Invest"},{"key":"2020040720052323200_CIT0057","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"Gerhard","year":"1981","journal-title":"Nature"},{"key":"2020040720052323200_CIT0058","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0042-6822(80)90372-4","article-title":"Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance","volume":"104","author":"Webster","year":"1980","journal-title":"Virology"},{"key":"2020040720052323200_CIT0059","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1073\/pnas.81.6.1779","article-title":"A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody","volume":"81","author":"Skehel","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020040720052323200_CIT0060","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JVI.02477-07","article-title":"Crystal structure of unliganded influenza B virus hemagglutinin","volume":"82","author":"Wang","year":"2008","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0061","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01100-18","article-title":"Immunodominance of antigenic site B in the hemagglutinin of the current H3N2 influenza virus in humans and mice","volume":"92","author":"Broecker","year":"2018","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0062","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1172\/JCI122895","article-title":"Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance","volume":"128","author":"Liu","year":"2018","journal-title":"J Clin Invest"},{"key":"2020040720052323200_CIT0063","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01673-18","article-title":"Antibody responses towards the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets and humans [manuscript published online ahead of 31 October 2018]","author":"Sun","year":"2018","journal-title":"J Virol"},{"key":"2020040720052323200_CIT0064","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"2020040720052323200_CIT0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"2020040720052323200_CIT0066","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines","volume":"9","author":"Krammer","year":"2018","journal-title":"MBio"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/Supplement_1\/S62\/28263974\/jiy711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/Supplement_1\/S62\/28263974\/jiy711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T01:21:45Z","timestamp":1586308905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/Supplement_1\/S62\/5304926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":66,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2019,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy711","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,15]]},"published":{"date-parts":[[2019,4,8]]}}}